Epidemiological Factors Associated with COVID-19 Clusters in Medical and Social Welfare Facilities.

COVID-19 cluster-based approach medical facilities social welfare facilities

Journal

Japanese journal of infectious diseases
ISSN: 1884-2836
Titre abrégé: Jpn J Infect Dis
Pays: Japan
ID NLM: 100893704

Informations de publication

Date de publication:
24 May 2022
Historique:
pubmed: 2 11 2021
medline: 28 5 2022
entrez: 1 11 2021
Statut: ppublish

Résumé

The characteristics of coronavirus disease 2019 (COVID-19) clusters in medical and social welfare facilities and the factors associated with cluster size are still not yet fully understood. We reviewed COVID-19 cases in Japan identified from January 15 to April 30, 2020 and analyzed the factors associated with cluster size in medical and social welfare facilities. In this study, COVID-19 clusters were identified in 56 medical and 34 social welfare facilities. The number of cases in those facilities peaked after the peak of the general population. The duration of occurrence of new cases in clusters was positively correlated with the number of cases in both types of facilities (rho = 0.44, P < 0.001; and rho = 0.69, P < 0.001, respectively). However, the number of days between the first case in a prefecture and the onset of clusters was negatively correlated with the number of cases only in clusters in social welfare facilities (rho = - 0.4, P = 0.004). Our results suggest that COVID-19 cases in those facilities were prevalent in the latter phase of the disease's community transmission, although the underlying mechanisms for such a trend could differ between medical and social welfare facilities.

Identifiants

pubmed: 34719529
doi: 10.7883/yoken.JJID.2021.288
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

281-287

Auteurs

Tadatsugu Imamura (T)

Japan International Cooperation Agency, Japan.
Center for Postgraduate Education and Training, National Center for Child Health and Development, Japan.

Yura K Ko (YK)

Department of Virology, Tohoku University Graduate School of Medicine, Japan.
Infectious Disease Surveillance Center, National Institute of Infectious Diseases, Japan.

Yuki Furuse (Y)

Institute for Frontier Life and Medical Sciences, Kyoto University, Japan.

Takeaki Imamura (T)

Department of Virology, Tohoku University Graduate School of Medicine, Japan.

Kazuaki Jindai (K)

Department of Healthcare Epidemiology, Kyoto University, Japan.

Reiko Miyahara (R)

Infectious Disease Surveillance Center, National Institute of Infectious Diseases, Japan.
Medical Genome Science Project, National Center for Global Health and Medicine, Japan.

Eiichiro Sando (E)

Department of General Internal Medicine & Clinical Infectious Diseases, Fukushima Medical University, Japan.

Ikkoh Yasuda (I)

Department of General Internal Medicine & Clinical Infectious Diseases, Fukushima Medical University, Japan.

Naho Tsuchiya (N)

Yamato-Clinic, Japan.
Tohoku Medical Megabank Organization, Tohoku University, Japan.

Mayuko Saito (M)

Department of Virology, Tohoku University Graduate School of Medicine, Japan.

Motoi Suzuki (M)

Infectious Disease Surveillance Center, National Institute of Infectious Diseases, Japan.

Hitoshi Oshitani (H)

Department of Virology, Tohoku University Graduate School of Medicine, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH